Highly effective prevention drug arrives in South Africa, which has world’s highest HIV burden
South Africa has begun the rollout of lenacapavir, a twice-yearly injectable drug that has shown 100% effectiveness in preventing HIV during clinical trials. The country, which holds the world's highest HIV burden, is positioning the drug as a major turning point in its public health strategy.
Why it matters
The introduction of a highly effective, long-acting preventative treatment could drastically reduce new HIV infection rates in high-burden regions.
Growing up witnessing the devastating effects of HIV in her family and community in South Africa pushed Olwam Plaatjie to start using preventive HIV medications three years ago.
The article reports on medical advancements and public health policy with a neutral, factual tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in